Document Classification

Section Type: METHODS

Text: From 1 January, 1985 to 31 December, 1989, 487 patients were randomized between MP (melphalan 9 mg/m (2) p. o. and prednisone 60 mg/m (2) days 1-4) and alternating VCMP (vincristine 1 mg i. v. on day 1, cyclophosphamide 500 mg/m (2) i. v. on day 1, melphalan 6 mg/m (2) p. o. on days 1-4, and prednisone 60 mg/m (2) on days 1-4) and VBAP (vincristine 1 mg i. v. on day 1, BCNU and doxorubicin 30 mg/m (2) i. v. each on day 1, and prednisone 60 mg/m (2) on days 1-4).